Your scientific partner for drug and therapeutic development

VascularStrategies is a contract research organization supporting pharmaceutical and biotech companies through preclinical and Phase I-IV studies of drug development utilizing assays of novel functional endpoints.

VascularStrategies has established a reputation for expertise, flexibility, consultation, and outstanding client services in the pharmaceutical outsourcing industry. With a growing list of validated biomarker assays and a network of scientific and technology expertise, VascularStrategies provides research services for many pharmaceutical and biotech companies, large and small, to support their development of cardiovascular disease therapies as quickly and cost effectively as possible. VascularStrategies provides GMP, GLP and GCLP compliant research services, as well as early stage research and development.